Medicines Australia welcomes new members
7 August 2023: Two new members have joined Medicines Australia following approval by the Medicines Australia board at its August meeting – Kyowa Kirin and MedWise Consulting.
Kyowa Kirin is a Japan-owned pharmaceutical company specialising in antibody technologies in therapeutic areas of oncology, nephrology, central nervous system and immunotherapy.
MedWise is an Australian company that specialises in industry leading consulting services in medical affairs, medical communications and patient engagement.
Medicines Australia CEO Liz de Somer, welcomed the companies’ commitment to participating in Australia’s pharmaceutical industry and policy environment.
“Medicines Australia plays an essential role in driving policy outcomes to ensure Australians have universal, affordable and fast access to treatments that keep pace with advancements in medicines,” Ms de Somer said.
“We rely on the participation of our members to help keep the Government and the community up-to-date with scientific advancements so that policy decisions are informed by our members who are at the frontline of research and development.”
“The addition of new members that specialise in innovative biopharmaceuticals will strengthen our advocacy for the benefit of the broader industry and most importantly, patients.”
Simon Dawson, Kyowa Kirin’s General Manager – Australia, said the company looks forward to working closely with Medicines Australia and industry peers.
“As Kyowa Kirin prepares to celebrate four years of operation in Australia, we are excited to join Medicines Australia as the industry body for the innovative biopharmaceutical sector.
“As our business grows and evolves, we remain focused on cutting-edge science to deliver novel medicines with life-changing value for Australians living with rare diseases and other unmet medical needs.”
Matt Britland, MedWise Managing Director, said being a member of Medicines Australia will enable MedWise to contribute to the broader ecosystem and ultimately improve patient outcomes.
“MedWise Consulting is proud to join Medicines Australia. We have joined to contribute to the broader ecosystem which we need to better patient outcomes. We firmly believe that by doing so, we can enhance patient outcomes, optimise the quality use of medical innovations, and ultimately improve lives.”
ENDS
__________________________________________________________________________________
Media enquiries to Kate McKeown, Senior Manager Communications and Media – kate.mckeown@medicinesaustralia.com.au or 0408 775 288.